Ionis Pharmaceuticals (IONS) and Biogen (BIIB) Report Updates on tofersen Phase 3 VALOR study in SOD1-ALS

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/21/2026

1. DSX
2. GNK
3. INTC
4. III
5. TTEC
6. DAL
7. AWK
8. SPCX
9. KWM
10. RAY-A

Go back to Ionis Pharmaceuticals (IONS) and Biogen (BIIB) Report Updates on tofersen Phase 3 VALOR study in SOD1-ALS
(NASDAQ: IONS) Delayed: 74.12 -0.19 (0.26%)
Previous Close $74.31    52 Week High $62.68 
Open $75.00    52 Week Low $19.59 
Day High $75.66    P/E N/A 
Day Low $73.50    EPS $0.00 
Volume 2,984,375